MedPath

Health And Diet, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

21

Active:0
Completed:13

Trial Phases

4 Phases

Phase 1:9
Phase 2:8
Phase 3:3
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials

Phase 1
9 (42.9%)
Phase 2
8 (38.1%)
Phase 3
3 (14.3%)
Phase 4
1 (4.8%)

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception

Phase 1
Recruiting
Conditions
Healthy Women
Female Contraception
First Posted Date
2019-10-29
Last Posted Date
2023-08-15
Lead Sponsor
Health Decisions
Target Recruit Count
136
Registration Number
NCT04143659
Locations
🇺🇸

University of California, Davis, Davis, California, United States

🇺🇸

Comprehensive Women's Health Center, Denver, Colorado, United States

🇺🇸

Boston Medical Center Corporation, Boston, Massachusetts, United States

and more 4 locations

Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg

Phase 4
Conditions
Contraception
Interventions
First Posted Date
2018-05-25
Last Posted Date
2019-10-08
Lead Sponsor
Health Decisions
Target Recruit Count
1200
Registration Number
NCT03537768
Locations
🇺🇸

Essential Access Health, Los Angeles, California, United States

🇺🇸

University of California, Davis, Sacramento, California, United States

🇺🇸

University of California, San Francisco, San Francisco, California, United States

and more 15 locations

Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

Phase 2
Conditions
Healthy
Male Contraception
Men
Interventions
Drug: Dimethandrolone-Undecanoate
Drug: Placebo oral capsule
First Posted Date
2018-03-06
Last Posted Date
2019-08-12
Lead Sponsor
Health Decisions
Target Recruit Count
100
Registration Number
NCT03455075
Locations
🇺🇸

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States

🇺🇸

University of Washington Medical Center & Health Sciences, Seattle, Washington, United States

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

Phase 2
Completed
Conditions
Men
Healthy
Male Contraception
Interventions
First Posted Date
2018-03-02
Last Posted Date
2025-02-18
Lead Sponsor
Health Decisions
Target Recruit Count
420
Registration Number
NCT03452111
Locations
🇺🇸

UC Davis Health, Sacramento, California, United States

🇺🇸

The Lunquist Institute at Harbor-UCLA Medical Center, Torrance, California, United States

🇺🇸

Comprehensive Women's Health Center, Denver, Colorado, United States

and more 14 locations

Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring

Phase 2
Conditions
Healthy Women
Female Contraception
Interventions
First Posted Date
2018-02-14
Last Posted Date
2019-05-20
Lead Sponsor
Health Decisions
Target Recruit Count
300
Registration Number
NCT03432416
Locations
🇺🇸

Essential Access Health, Los Angeles, California, United States

🇺🇸

University of California, Davis, Sacramento, California, United States

🇺🇸

University of Colorado Denver, Aurora, Colorado, United States

and more 8 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath